Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
comparative study between tadalafil versus placebo effect for the management of circumsized female
the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| tadalafil group | Active Comparator | 5 mg of Tadalafil on daily bases for one month duration |
|
| placebo group | Placebo Comparator | the patients will receive oral tablets without any active substance for one month |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tadalafil 5mg | Drug | oral tablets for one month duration |
| |
| Measure | Description | Time Frame |
|---|---|---|
| clitorial Artery Doppler | Pulsatile index | after one month duration of drug use |
| Clitorial artery doppler | Resistance index | after one month duration of drug use |
| Clitorial artery doppler | Peak systolic velosity | after one month duration of drug use |
| Measure | Description | Time Frame |
|---|---|---|
| score of sexual function | arousal orgasm frequency | after on month of the drug use |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kasr Elainy | Cairo | Egypt |
the exel sheet
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012735 | Sexual Dysfunction, Physiological |
| ID | Term |
|---|---|
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068581 | Tadalafil |
| ID | Term |
|---|---|
| D002243 | Carbolines |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo |
| Drug |
oral tablets for one month duration |
|
| D026121 |
| Indole Alkaloids |
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006575 | Heterocyclic Compounds, 3-Ring |